2024 annual financial data
Cardiff Oncology 2024 Operating margin
Direct answer
Operating margin was -7,123.13%.
Operating income was -48,651,000 USD and net income was -45,431,000 USD.
Operating cash flow was -37,693,000 USD.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 683,000 USD
- Operating income
- -48,651,000 USD
- Net income
- -45,431,000 USD
- Operating cash flow
- -37,693,000 USD